- Home
- / Madrigal Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Madrigal Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$217.8
2024-10-29
Market Capitalization
$4.7 B
2024-10-29
Revenue
$958.4 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 180.1M | 958.4M | |||||||||||||
| Cost of goods sold | 6.2M | ||||||||||||||
| Gross profit | 173.9M | ||||||||||||||
| Gross profit margin, % | 96.5% | ||||||||||||||
| General and administrative expense | 11.6M | 11.7M | 15.7M | 15.7M | 13.4M | 9.3M | 7.7M | 15.3M | 22.6M | 21.9M | 37.3M | 48.1M | 108.1M | 435.1M | 813.8M |
| Operating expense total | 53.0M | 61.1M | 87.6M | 84.0M | 67.6M | 25.2M | 32.1M | 40.7M | 95.0M | 206.7M | 293.6M | 380.5M | 671.8M | 1.2B | |
| EBIT | (45.4M) | (60.9M) | (87.6M) | (84.0M) | (67.6M) | (25.2M) | (32.1M) | (40.7M) | (95.0M) | (206.7M) | (242.5M) | (293.6M) | (380.5M) | (497.9M) | (300.1M) |
| EBIT margin, % | -276.4% | -31.3% | |||||||||||||
| Interest income | 48.3K | 558.0K | 7.7M | 11.0M | 4.3M | 363.0K | 2.2M | 19.6M | 46.7M | 37.4M | |||||
| Interest expense | 1.9M | 1.8M | 2.6M | 2.2M | 1.1M | 12.7M | 32.0M | ||||||||
| Pre tax profit | (158.5M) | ||||||||||||||
| Net Income | (47.4M) | (62.8M) | (90.2M) | (86.2M) | (68.7M) | (26.4M) | (31.2M) | (32.8M) | (83.9M) | (202.2M) | (241.8M) | (295.3M) | (373.6M) | (465.9M) | (288.3M) |
| EPS | (17.2) | (20.0) | (21.9) | (12.8) |